The global Carbapenem Antibiotics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Meropenem segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Carbapenem Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Carbapenem Antibiotics manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Carbapenem Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem Antibiotics. This report contains market size and forecasts of Carbapenem Antibiotics in global, including the following market information:
Global Carbapenem Antibiotics market revenue, 2020-2025, 2026-2032, ($ millions)
Global Carbapenem Antibiotics market sales, 2020-2025, 2026-2032, (Tons)
Global top five Carbapenem Antibiotics companies in 2024 (%)
Total Market by Segment:
Global Carbapenem Antibiotics market, by Type, 2020-2025, 2026-2032 ($ millions) & (Tons)
Global Carbapenem Antibiotics market segment percentages, by Type, 2024 (%)
Meropenem
Donipenem
Imipenem
Tipipenem
Others
Global Carbapenem Antibiotics market, by Application, 2020-2025, 2026-2032 ($ Millions) & (Tons)
Global Carbapenem Antibiotics market segment percentages, by Application, 2024 (%)
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Global Carbapenem Antibiotics market, by region and country, 2020-2025, 2026-2032 ($ millions) & (Tons)
Global Carbapenem Antibiotics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Carbapenem Antibiotics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Carbapenem Antibiotics revenues share in global market, 2024 (%)
Key companies Carbapenem Antibiotics sales in global market, 2020-2025 (estimated), (Tons)
Key companies Carbapenem Antibiotics sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Carbapenem Antibiotics, market overview.
Chapter 2: Global Carbapenem Antibiotics market size in revenue and volume.
Chapter 3: Detailed analysis of Carbapenem Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Carbapenem Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Carbapenem Antibiotics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Carbapenem Antibiotics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Carbapenem Antibiotics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Carbapenem Antibiotics Overall Market Size
2.1 Global Carbapenem Antibiotics Market Size: 2024 VS 2032
2.2 Global Carbapenem Antibiotics Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Carbapenem Antibiotics Sales: 2020-2032
3 Company Landscape
3.1 Top Carbapenem Antibiotics Players in Global Market
3.2 Top Global Carbapenem Antibiotics Companies Ranked by Revenue
3.3 Global Carbapenem Antibiotics Revenue by Companies
3.4 Global Carbapenem Antibiotics Sales by Companies
3.5 Global Carbapenem Antibiotics Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Carbapenem Antibiotics Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Carbapenem Antibiotics Product Type
3.8 Tier 1, Tier 2, and Tier 3 Carbapenem Antibiotics Players in Global Market
3.8.1 List of Global Tier 1 Carbapenem Antibiotics Companies
3.8.2 List of Global Tier 2 and Tier 3 Carbapenem Antibiotics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Carbapenem Antibiotics Market Size Markets, 2024 & 2032
4.1.2 Meropenem
4.1.3 Donipenem
4.1.4 Imipenem
4.1.5 Tipipenem
4.1.6 Others
4.2 Segment by Type - Global Carbapenem Antibiotics Revenue & Forecasts
4.2.1 Segment by Type - Global Carbapenem Antibiotics Revenue, 2020-2025
4.2.2 Segment by Type - Global Carbapenem Antibiotics Revenue, 2026-2032
4.2.3 Segment by Type - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Carbapenem Antibiotics Sales & Forecasts
4.3.1 Segment by Type - Global Carbapenem Antibiotics Sales, 2020-2025
4.3.2 Segment by Type - Global Carbapenem Antibiotics Sales, 2026-2032
4.3.3 Segment by Type - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
4.4 Segment by Type - Global Carbapenem Antibiotics Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Carbapenem Antibiotics Market Size, 2024 & 2032
5.1.2 Retail Pharmacy
5.1.3 Online Pharmacy
5.1.4 Hospital Pharmacy
5.2 Segment by Application - Global Carbapenem Antibiotics Revenue & Forecasts
5.2.1 Segment by Application - Global Carbapenem Antibiotics Revenue, 2020-2025
5.2.2 Segment by Application - Global Carbapenem Antibiotics Revenue, 2026-2032
5.2.3 Segment by Application - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Carbapenem Antibiotics Sales & Forecasts
5.3.1 Segment by Application - Global Carbapenem Antibiotics Sales, 2020-2025
5.3.2 Segment by Application - Global Carbapenem Antibiotics Sales, 2026-2032
5.3.3 Segment by Application - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
5.4 Segment by Application - Global Carbapenem Antibiotics Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Carbapenem Antibiotics Market Size, 2024 & 2032
6.2 By Region - Global Carbapenem Antibiotics Revenue & Forecasts
6.2.1 By Region - Global Carbapenem Antibiotics Revenue, 2020-2025
6.2.2 By Region - Global Carbapenem Antibiotics Revenue, 2026-2032
6.2.3 By Region - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
6.3 By Region - Global Carbapenem Antibiotics Sales & Forecasts
6.3.1 By Region - Global Carbapenem Antibiotics Sales, 2020-2025
6.3.2 By Region - Global Carbapenem Antibiotics Sales, 2026-2032
6.3.3 By Region - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Carbapenem Antibiotics Revenue, 2020-2032
6.4.2 By Country - North America Carbapenem Antibiotics Sales, 2020-2032
6.4.3 United States Carbapenem Antibiotics Market Size, 2020-2032
6.4.4 Canada Carbapenem Antibiotics Market Size, 2020-2032
6.4.5 Mexico Carbapenem Antibiotics Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Carbapenem Antibiotics Revenue, 2020-2032
6.5.2 By Country - Europe Carbapenem Antibiotics Sales, 2020-2032
6.5.3 Germany Carbapenem Antibiotics Market Size, 2020-2032
6.5.4 France Carbapenem Antibiotics Market Size, 2020-2032
6.5.5 U.K. Carbapenem Antibiotics Market Size, 2020-2032
6.5.6 Italy Carbapenem Antibiotics Market Size, 2020-2032
6.5.7 Russia Carbapenem Antibiotics Market Size, 2020-2032
6.5.8 Nordic Countries Carbapenem Antibiotics Market Size, 2020-2032
6.5.9 Benelux Carbapenem Antibiotics Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Carbapenem Antibiotics Revenue, 2020-2032
6.6.2 By Region - Asia Carbapenem Antibiotics Sales, 2020-2032
6.6.3 China Carbapenem Antibiotics Market Size, 2020-2032
6.6.4 Japan Carbapenem Antibiotics Market Size, 2020-2032
6.6.5 South Korea Carbapenem Antibiotics Market Size, 2020-2032
6.6.6 Southeast Asia Carbapenem Antibiotics Market Size, 2020-2032
6.6.7 India Carbapenem Antibiotics Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Carbapenem Antibiotics Revenue, 2020-2032
6.7.2 By Country - South America Carbapenem Antibiotics Sales, 2020-2032
6.7.3 Brazil Carbapenem Antibiotics Market Size, 2020-2032
6.7.4 Argentina Carbapenem Antibiotics Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Carbapenem Antibiotics Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Carbapenem Antibiotics Sales, 2020-2032
6.8.3 Turkey Carbapenem Antibiotics Market Size, 2020-2032
6.8.4 Israel Carbapenem Antibiotics Market Size, 2020-2032
6.8.5 Saudi Arabia Carbapenem Antibiotics Market Size, 2020-2032
6.8.6 UAE Carbapenem Antibiotics Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 ACS Dobfar S.p.A
7.1.1 ACS Dobfar S.p.A Company Summary
7.1.2 ACS Dobfar S.p.A Business Overview
7.1.3 ACS Dobfar S.p.A Carbapenem Antibiotics Major Product Offerings
7.1.4 ACS Dobfar S.p.A Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.1.5 ACS Dobfar S.p.A Key News & Latest Developments
7.2 Iterum Therapeutics plc
7.2.1 Iterum Therapeutics plc Company Summary
7.2.2 Iterum Therapeutics plc Business Overview
7.2.3 Iterum Therapeutics plc Carbapenem Antibiotics Major Product Offerings
7.2.4 Iterum Therapeutics plc Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.2.5 Iterum Therapeutics plc Key News & Latest Developments
7.3 DAEWOONG PHARMACEUTICAL CO.,LTD
7.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Summary
7.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
7.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Major Product Offerings
7.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Key News & Latest Developments
7.4 Aurobindo Pharma Ltd
7.4.1 Aurobindo Pharma Ltd Company Summary
7.4.2 Aurobindo Pharma Ltd Business Overview
7.4.3 Aurobindo Pharma Ltd Carbapenem Antibiotics Major Product Offerings
7.4.4 Aurobindo Pharma Ltd Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.4.5 Aurobindo Pharma Ltd Key News & Latest Developments
7.5 Gland Pharma Limited
7.5.1 Gland Pharma Limited Company Summary
7.5.2 Gland Pharma Limited Business Overview
7.5.3 Gland Pharma Limited Carbapenem Antibiotics Major Product Offerings
7.5.4 Gland Pharma Limited Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.5.5 Gland Pharma Limited Key News & Latest Developments
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Carbapenem Antibiotics Major Product Offerings
7.6.4 Merck & Co., Inc. Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.6.5 Merck & Co., Inc. Key News & Latest Developments
7.7 Sumitomo Dainippon Pharma Co., Ltd.
7.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Summary
7.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
7.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Major Product Offerings
7.7.4 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.7.5 Sumitomo Dainippon Pharma Co., Ltd. Key News & Latest Developments
7.8 Savior Lifetec
7.8.1 Savior Lifetec Company Summary
7.8.2 Savior Lifetec Business Overview
7.8.3 Savior Lifetec Carbapenem Antibiotics Major Product Offerings
7.8.4 Savior Lifetec Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.8.5 Savior Lifetec Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Carbapenem Antibiotics Major Product Offerings
7.9.4 Pfizer Inc. Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Spero Therapeutics
7.10.1 Spero Therapeutics Company Summary
7.10.2 Spero Therapeutics Business Overview
7.10.3 Spero Therapeutics Carbapenem Antibiotics Major Product Offerings
7.10.4 Spero Therapeutics Carbapenem Antibiotics Sales and Revenue in Global (2020-2025)
7.10.5 Spero Therapeutics Key News & Latest Developments
8 Global Carbapenem Antibiotics Production Capacity, Analysis
8.1 Global Carbapenem Antibiotics Production Capacity, 2020-2032
8.2 Carbapenem Antibiotics Production Capacity of Key Manufacturers in Global Market
8.3 Global Carbapenem Antibiotics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Carbapenem Antibiotics Supply Chain Analysis
10.1 Carbapenem Antibiotics Industry Value Chain
10.2 Carbapenem Antibiotics Upstream Market
10.3 Carbapenem Antibiotics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Carbapenem Antibiotics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Carbapenem Antibiotics in Global Market
Table 2. Top Carbapenem Antibiotics Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Carbapenem Antibiotics Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Carbapenem Antibiotics Revenue Share by Companies, 2020-2025
Table 5. Global Carbapenem Antibiotics Sales by Companies, (Tons), 2020-2025
Table 6. Global Carbapenem Antibiotics Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Carbapenem Antibiotics Price (2020-2025) & (US$/Kg)
Table 8. Global Manufacturers Carbapenem Antibiotics Product Type
Table 9. List of Global Tier 1 Carbapenem Antibiotics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carbapenem Antibiotics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Carbapenem Antibiotics Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Carbapenem Antibiotics Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Carbapenem Antibiotics Sales (Tons), 2020-2025
Table 15. Segment by Type - Global Carbapenem Antibiotics Sales (Tons), 2026-2032
Table 16. Segment by Application � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 20. Segment by Application - Global Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 21. By Region � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 25. By Region - Global Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 26. By Country - North America Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 29. By Country - North America Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 30. By Country - Europe Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 33. By Country - Europe Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 34. By Region - Asia Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 37. By Region - Asia Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 38. By Country - South America Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 41. By Country - South America Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 42. By Country - Middle East & Africa Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Carbapenem Antibiotics Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Carbapenem Antibiotics Sales, (Tons), 2020-2025
Table 45. By Country - Middle East & Africa Carbapenem Antibiotics Sales, (Tons), 2026-2032
Table 46. ACS Dobfar S.p.A Company Summary
Table 47. ACS Dobfar S.p.A Carbapenem Antibiotics Product Offerings
Table 48. ACS Dobfar S.p.A Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 49. ACS Dobfar S.p.A Key News & Latest Developments
Table 50. Iterum Therapeutics plc Company Summary
Table 51. Iterum Therapeutics plc Carbapenem Antibiotics Product Offerings
Table 52. Iterum Therapeutics plc Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 53. Iterum Therapeutics plc Key News & Latest Developments
Table 54. DAEWOONG PHARMACEUTICAL CO.,LTD Company Summary
Table 55. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Product Offerings
Table 56. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 57. DAEWOONG PHARMACEUTICAL CO.,LTD Key News & Latest Developments
Table 58. Aurobindo Pharma Ltd Company Summary
Table 59. Aurobindo Pharma Ltd Carbapenem Antibiotics Product Offerings
Table 60. Aurobindo Pharma Ltd Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 61. Aurobindo Pharma Ltd Key News & Latest Developments
Table 62. Gland Pharma Limited Company Summary
Table 63. Gland Pharma Limited Carbapenem Antibiotics Product Offerings
Table 64. Gland Pharma Limited Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 65. Gland Pharma Limited Key News & Latest Developments
Table 66. Merck & Co., Inc. Company Summary
Table 67. Merck & Co., Inc. Carbapenem Antibiotics Product Offerings
Table 68. Merck & Co., Inc. Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 69. Merck & Co., Inc. Key News & Latest Developments
Table 70. Sumitomo Dainippon Pharma Co., Ltd. Company Summary
Table 71. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Product Offerings
Table 72. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 73. Sumitomo Dainippon Pharma Co., Ltd. Key News & Latest Developments
Table 74. Savior Lifetec Company Summary
Table 75. Savior Lifetec Carbapenem Antibiotics Product Offerings
Table 76. Savior Lifetec Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 77. Savior Lifetec Key News & Latest Developments
Table 78. Pfizer Inc. Company Summary
Table 79. Pfizer Inc. Carbapenem Antibiotics Product Offerings
Table 80. Pfizer Inc. Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 81. Pfizer Inc. Key News & Latest Developments
Table 82. Spero Therapeutics Company Summary
Table 83. Spero Therapeutics Carbapenem Antibiotics Product Offerings
Table 84. Spero Therapeutics Carbapenem Antibiotics Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 85. Spero Therapeutics Key News & Latest Developments
Table 86. Carbapenem Antibiotics Capacity of Key Manufacturers in Global Market, 2023-2025 (Tons)
Table 87. Global Carbapenem Antibiotics Capacity Market Share of Key Manufacturers, 2023-2025
Table 88. Global Carbapenem Antibiotics Production by Region, 2020-2025 (Tons)
Table 89. Global Carbapenem Antibiotics Production by Region, 2026-2032 (Tons)
Table 90. Carbapenem Antibiotics Market Opportunities & Trends in Global Market
Table 91. Carbapenem Antibiotics Market Drivers in Global Market
Table 92. Carbapenem Antibiotics Market Restraints in Global Market
Table 93. Carbapenem Antibiotics Raw Materials
Table 94. Carbapenem Antibiotics Raw Materials Suppliers in Global Market
Table 95. Typical Carbapenem Antibiotics Downstream
Table 96. Carbapenem Antibiotics Downstream Clients in Global Market
Table 97. Carbapenem Antibiotics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Carbapenem Antibiotics Product Picture
Figure 2. Carbapenem Antibiotics Segment by Type in 2024
Figure 3. Carbapenem Antibiotics Segment by Application in 2024
Figure 4. Global Carbapenem Antibiotics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Carbapenem Antibiotics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Carbapenem Antibiotics Revenue: 2020-2032 (US$, Mn)
Figure 8. Carbapenem Antibiotics Sales in Global Market: 2020-2032 (Tons)
Figure 9. The Top 3 and 5 Players Market Share by Carbapenem Antibiotics Revenue in 2024
Figure 10. Segment by Type � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Carbapenem Antibiotics Price (US$/Kg), 2020-2032
Figure 14. Segment by Application � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Carbapenem Antibiotics Price (US$/Kg), 2020-2032
Figure 18. By Region � Global Carbapenem Antibiotics Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Carbapenem Antibiotics Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 21. By Region - Global Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 22. By Country - North America Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 23. By Country - North America Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 24. United States Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 29. Germany Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 30. France Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Carbapenem Antibiotics Sales Market Share, 2020-2032
Figure 38. China Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 42. India Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Carbapenem Antibiotics Revenue Market Share, 2020-2032
Figure 44. By Country - South America Carbapenem Antibiotics Sales, Market Share, 2020-2032
Figure 45. Brazil Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Carbapenem Antibiotics Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Carbapenem Antibiotics Sales, Market Share, 2020-2032
Figure 49. Turkey Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Carbapenem Antibiotics Revenue, (US$, Mn), 2020-2032
Figure 53. Global Carbapenem Antibiotics Production Capacity (Tons), 2020-2032
Figure 54. The Percentage of Production Carbapenem Antibiotics by Region, 2024 VS 2032
Figure 55. Carbapenem Antibiotics Industry Value Chain
Figure 56. Marketing Channels
